ALLMED SOLUTIONS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 ILa | -2.07% |
|
-8.31% | -11.02% |
| Mar. 07 | Allmed Solutions Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Allmed Solutions Ltd announces an Equity Buyback for $1.5 million worth of its shares. | CI |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 40.22M 11M 4.02B |
|---|---|---|---|---|---|
| Net income 2022 | -12M -3.28M -1.2B | Net income 2023 | 1M 274K 100M | EV / Sales 2022 | - |
| Net cash position 2022 | 20.36M 5.57M 2.04B | Net cash position 2023 | 56.23M 15.38M 5.62B | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.78
x | P/E ratio 2023 |
28.3
x | Employees | 19 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.68% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.07% | ||
| 1 week | -8.31% | ||
| Current month | -15.13% | ||
| 1 month | -15.13% | ||
| 3 months | -25.28% | ||
| 6 months | -13.35% | ||
| Current year | -11.02% |
1 week
31.70
35.20
1 month
31.7041.90
Current year
31.7047.50
1 year
28.1047.50
3 years
24.2094.90
5 years
24.2094.90
10 years
24.20324.70
| Managers | Title | Age | Since |
|---|---|---|---|
Oz Moshe Shapira
CEO | Chief Executive Officer | 68 | 22-02-28 |
Asaf Alperovitz
BRD | Director/Board Member | 54 | 12-09-30 |
Mor Salomon Liss
AUD | Comptroller/Controller/Auditor | 38 | 21-10-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Milch
FOU | Founder | 68 | 04-01-03 |
Asaf Alperovitz
BRD | Director/Board Member | 54 | 12-09-30 |
| Director/Board Member | 55 | 22-08-02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 33.1 | -2.07% | 136,721 |
| 24-05-21 | 33.8 | -1.74% | 7,289 |
| 24-05-20 | 34.4 | -4.71% | 60,520 |
| 24-05-19 | 36.1 | 0.00% | 53,528 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 23, 2024 at 10:24 am EDT
More quotes
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.02% | 8.79M | |
| +12.05% | 128B | |
| -9.24% | 10.88B | |
| +0.29% | 8.76B | |
| +36.99% | 5.48B | |
| -21.98% | 4.72B | |
| +8.02% | 3.43B | |
| -10.32% | 2.76B | |
| -12.33% | 2.06B | |
| -13.53% | 1.92B |
- Stock Market
- Equities
- ALMD Stock
